Cases & Deals

Odyssey Thera raises capital in Series A round

Clients Odyssey Thera, Inc.

Jones Day represented Odyssey Thera, Inc., a research and development organization specializing in targeted therapies for cancer, in its issuance of new Series A Convertible Preferred Stock in a private placement to Merck & Co., Inc., Burrill & Company, HBM Partners, and Healthcap.